Trial intelligence / Profile preview

QLB for Pain Management After Lumbar Spinal Surgery

NCT04981301Completed

Sponsor
Istanbul Medipol University
Start
Aug 2021
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Visual Analog Scale at 24 hours. Started Aug 2021; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04981301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04981301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call